Bartnik Paweł, Kacperczyk-Bartnik Joanna, Goławski Ksawery, Sierdziński Janusz, Mańka Grzegorz, Kiecka Mariusz, Lipa Michał, Warzecha Damian, Spaczyński Robert, Piekarski Piotr, Banaszewska Beata, Jakimiuk Artur J, Issat Tadeusz, Rokita Wojciech, Młodawski Jakub, Szubert Maria, Sieroszewski Piotr, Raba Grzegorz, Szczupak Kamil, Kluz Tomasz, Kluza Marek, Czajkowski Krzysztof, Wielgoś Mirosław, Koc-Żórawska Ewa, Żórawski Marcin, Laudański Piotr
II Department of Obstetrics and Gynecology, Medical University of Warsaw, 00-315 Warsaw, Poland.
Club 35. Polish Society of Gynecologists and Obstetricians, 53-125 Wrocław, Poland.
Biomedicines. 2022 Oct 1;10(10):2460. doi: 10.3390/biomedicines10102460.
Zinc finger E-box-binding homeobox 1 (ZEB1) and zinc finger E-box-binding homeobox 2 (ZEB2) are transcription factors that regulate epithelial−mesenchymal transformation (EMT). The aim of this study was to compare levels of ZEB1 and ZEB2 in the peritoneal fluid and plasma between patients with and without endometriosis in order to assess their utility in the diagnostic process. Plasma and peritoneal fluid samples were collected from 50 patients with and 48 without endometriosis during planned surgical procedures in eight clinical centers. Quantitative ZEB1 and ZEB2 levels analyses were performed using a double-antibody sandwich enzyme-linked immunosorbent assay (ELISA). No significant differences were observed in ZEB1 levels in any of the subanalyses nor any differences regarding ZEB2 levels between patients with and without endometriosis. Plasma ZEB2 levels were significantly higher among patients with infertility compared to fertile women (16.07 ± 12.70 ng/L vs. 12.07 ± 11.92 ng/L; p < 0.04). Both ZEB1 and ZEB2 do not seem to have a significant value in the initial diagnosis of endometriosis as a single marker. The differences in ZEB2 plasma levels between patients with and without infertility indicate the possibility of EMT dysregulation in the pathogenesis of adverse fertility outcomes.
锌指 E 盒结合同源框 1(ZEB1)和锌指 E 盒结合同源框 2(ZEB2)是调节上皮-间质转化(EMT)的转录因子。本研究的目的是比较子宫内膜异位症患者和非子宫内膜异位症患者腹腔液和血浆中 ZEB1 和 ZEB2 的水平,以评估它们在诊断过程中的效用。在八个临床中心的计划性手术过程中,从 50 例子宫内膜异位症患者和 48 例非子宫内膜异位症患者中采集了血浆和腹腔液样本。使用双抗体夹心酶联免疫吸附测定(ELISA)进行 ZEB1 和 ZEB2 水平的定量分析。在任何亚分析中,子宫内膜异位症患者和非子宫内膜异位症患者之间的 ZEB1 水平均未观察到显著差异,ZEB2 水平也无差异。与有生育能力的女性相比,不孕患者的血浆 ZEB2 水平显著更高(16.07±12.70 ng/L 对 12.07±11.92 ng/L;p<0.04)。ZEB1 和 ZEB2 作为单一标志物,在子宫内膜异位症的初步诊断中似乎均无显著价值。有不孕和无不孕的患者之间 ZEB2 血浆水平的差异表明,EMT 失调可能在不良生育结局的发病机制中起作用。